Spero Therapeutics, Inc. (SPRO)
2.24
-0.06
(-2.61%)
USD |
NASDAQ |
Feb 23, 14:04
Spero Therapeutics Market Cap : 126.20M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 12.29B |
| Amicus Therapeutics, Inc. | 4.500B |
| Cassava Sciences, Inc. | 102.90M |
| Alpha Teknova, Inc. | 112.95M |
| Pyxis Oncology, Inc. | 89.35M |
Market Cap Related Metrics
| PS Ratio | 4.245 |
| Price to Book Value | 4.763 |
| Price | 2.24 |
| Earnings Yield | -35.49% |